RBC Capital analyst Leonid Timashev maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report) today and set a price target of ...
In a report released yesterday, Lawson Winder from Bank of America Securities reiterated a Buy rating on Triple Flag Precious Metals (TFPM – ...